NEURO62

NEURO62

May 19 - May 22, 2021Kyoto International Conference Center
Annual Meeting of the Japanese Society of Neurology
NEURO62

NEURO62

May 19 - May 22, 2021Kyoto International Conference Center

[NFS-02-2]Applications of AI to Elucidate Mechanisms of Neurodegenerative Disease in Models and Patients

Steve Finkbeiner(Gladstone Institutes, UCSF, USA)
photo
Dr. Steve Finkbeiner is Director of the Center for Systems and Therapeutics and Taube/Koret Center for Neurodegenerative Disease Research at Gladstone Institutes, and is a Professor of Neurology and Physiology at the University of California, San Francisco. He earned a bachelor’s degree from Wheaton College (1986), and concurrently earned an MD and a PhD in neuroscience from Yale University (1991). He completed an internship in internal medicine (1992) and chief residency (1995) in neurology at the University of California, San Francisco, followed by a research fellowship at Harvard Medical School (1998). Work in his academic research laboratory has focused on studying the molecular mechanisms that are responsible for learning, memory and neurodegeneration. A major focus of his work in the area of neurodegenerative disease has been the role of protein dyshomeostasis in HD, PD, ALS, and FTD. In this context, he has developed a robotic microscopy, a unique fully automated high throughput single cell analysis platform that provides very sensitive measures of phenotypes. This technology has been used to discover disease-related phenotypes in differentiated neurons from patients with neurodegenerative diseases to better understand mechanisms of disease, and to find and develop therapeutic strategies.

Password required to view

Abstract password authentication.
Password is written on a pocket program and name badge.